Healthy New Jersey

Information on
Novel Coronavirus

Coronavirus is still active in NJ. Wear a mask. Keep a 6ft. distance in public

NJ Poison Control Center and 211 provide COVID-19 information: Call: 2-1-1; Call (24/7); 1-800-962-1253; Text: NJCOVID to 898-211; More Information:
COVID19 Alert NJDownload COVID Alert NJ app for free today.

Division of Medicinal Marijuana


COVID-19 Information

COVID-19 Information

Due to the COVID-19 outbreak, the Division of Medicinal Marijuana Customer Service line has temporarily changed.  To reach a customer service representative, please call 844-419-9712.  Again, due to the COVID-19 outbreak, please call 844-419-9712 to reach a Medicinal Marijuana Customer Service Representative.  Thank you.

Seeking New Alternative Treatment Centers

Seeking New Alternative Treatment Centers

Proceedings related to the July 1st 2019 Request for Applications for new Alternative Treatment Centers are currently stayed (paused) by the Superior Court of New Jersey, Appellate Division.  Please note that the RFA is still pending and all requirements as outlined in the July 1, 2019 Notice and related materials remain in effect for applicants in contention. All publicly released RFA materials are available for review (from both 2018 and 2019) in the RFA document library.

Learn More >

Medicinal Marijuana Program Now Serves Over 72,000 Patients

Medicinal Marijuana Program Now Serves Over 80,000 Patients

Following the addition of new qualifying medical conditions as well as lowered patient and caregiver fees, the Medicinal Marijuana Program has seen the number of patients in the program more than triple since the day Governor Murphy took office in January. 81,111 patients are in the program. 1,194 doctors and 3,172 caregivers also participate.

Learn More >

 Jake Honig Compassionate Use Medical Cannabis Act

Jake Honig Compassionate Use Medical Cannabis Act

The new law dramatically reforms the Medicinal Marijuana Program and expands patient access to medical marijuana.

Learn More >

Frequently Asked Questions
  • Use the following links to find answers to the MMP's most frequently asked questions. Due to the development of the program, questions and answers are subject to change. Visit this section periodically to stay updated with current information.

  • Patient FAQs

  • Physician FAQs

  • ATC FAQs

ATC RFA Document Library
  • Following a request for ATC applications in summer 2018, the Department selected six applicants to continue the ATC approval process in December 2018. The Department also made a request for ATC applications in summer 2019.

  • Read Press Release

  • Document Library

Contact Us

to top